Bavarian Biotech Report 2011/2012 (7MB) - Bio M

probior GmbHBIOTECH DEVICES & REAGENTSprobior distributes products for biotechnology, medicine and pharmacy. Wecarry a wide selection of high quality reagents and assay kits for HighThroughput Screening manufactured by our Japanese partner Dojindo.We offer fast and convenient assay kits for protein labeling, DNA/RNA isolation,cell viability/cytotoxicity and oxidative stress. There are also high-purityreagents available e.g. for cell staining, NO research, diagnostic analysis, andalso Self Assembled Monolayer, HPLC reagents, detergents, good’s buffer.Contact:Dr. Christian PhilippErnsbergerstr. 5aD-81241 MünchenPhone: +49 (0) 89 580081-20Fax: +49 (0) 89 580081-22E-Mail: info@probior.comInternet: www.probior.comProJect Pharmaceutics GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Small Molecules, Peptide/Protein, Antibody, Liposomes, DrugDelivery, Drug DevelopmentTransforming proteins into pioneering drugsProJect Pharmaceutics, based in Martinsried/Munich, Germany, transformsproteins, peptides and delicate small molecules into pioneering drugs.ProJect Pharmaceutics adds value to client’s bio-pharmaceutical products byapplying an innovative concept of development called Advaceutics. Basedon the Advaceutics concept, ProJect Pharmaceutics designs optimized formulationsand delivery systems for biologics that are stable, convenient andsafe. Tailored to these optimized systems the company develops cost-effectivemanufacturing processes and transfers those from its own pilot labs tolarge-scale manufacturing. ProJect Pharmaceutics makes sure that investigationalproducts, biosimilars as well as “bio-betters” are developed effectivelyand will run smoothly in clinical and commercial scale GMP manufacturing.ProJect Pharmaceutics was founded and is managed by AndreasSchütz and Klaus Hellerbrand, two leading experts in protein formulationand pharmaceutical process development with many years of experience inbio-pharmaceutics. Their combined expertise and complementary set ofqualifications enables ProJect Pharmaceutics to deliver the high-tech pharmaceuticalservices that are in increased demand for the global biopharmaceuticalindustry.We offer:predictive formulation analytics formulation development including indepthprotein analytics lyophilization process development and optimizationlyophilization in dual chamber prefilled syringe development ofliposomal formulations, producible by simple stirring manufacturing ofpreclinical study material technology-transfer including scale-up to GMPmanufacturerWe deliver:optimized formulations for biopharmaceuticals tailored manufacturingprocesses and transfer to GMP manufacturing development reports readyfor submission to the authorities for registrationFor more information please visit: www.project-pharmaceutics.comContact:Dr. Andreas SchützFraunhoferstr. 22D-82152 MartinsriedPhone: +49 (0) 89 452289-700Fax: +49 (0) 89 452289-717E-Mail: info@project-pharmaceutics.comInternet: www.project-pharmaceutics.com105